9
074 J . Org. Chem., Vol. 63, No. 24, 1998
Meyer et al.
+
NMR δ 9.29 [s, 1H, isoxazole C(5)-H], 8.41 (m, 1H, NH), 7.70
m, 2H, PhH), 7.46 (m, 3H, PhH), 5.85-5.69 (m, 14H), 4.89-
.80 (m, 7H), 4.56-4.44 (m, 6H), 3.81-3.29 (m, 42H); 13C NMR
δ 160.9 (isoxazole C-5), 160.7 and 159.8 (quaternary), 130.0,
28.6 and 128.5 (methine, Ph), 127.8 (quaternary, Ph), 115.7
isoxazole C-4), 102.4-101.8 (CD C-1), 83.8 and 81.8-81.3 (CD
C-4), 73.0-72.0 and 69.8 (CD C-2, C-3, and C-5) 60.1-59.7
t-Bu); ESI-MS m/z 1385 (M + Na ). Anal. Calcd for
O: C, 45.16; H, 6.77; N, 1.88. Found: C,
45.38; H, 6.68; N, 1.49.
(
4
C
56
H
86
N
2
O
36‚7H
2
A
A
tr a n s-N-(6 -Deoxy-â-cyclod ext r in -6 -yl)-4-(a m in oca r -
bon yl)-3-(4-ter t-bu tylp h en yl)-4,5-d ih yd r oisoxa zole-5-ca r -
boxylic a cid (14c). The title compound was prepared as a
3:1 mixture with the regioisomer 15c, in 100% yield, as
described above from reaction of the CD 8b with the nitrile
oxide 11a in aqueous solution. It was isolated by HPLC
1
(
+
(
CD C-6); ESI-MS m/z 1327 (M + Na ). Anal. Calcd for
O: C, 45.95; H, 6.08; N, 2.06. Found: C,
6.19; H, 5.85; N, 2.12.
C
4
52
H
76
N
2
O
36‚3H
2
(acetonitrile/water, 10% v/v) and had the following: HPLC t
R
A
A
1
N-(6 -Deoxy-â-cyclod extr in -6 -yl)-5-(a m in oca r bon yl)-
) 1.0; H NMR δ 8.27 (br s, 1H, NH), 7.47 (d, 2H, J ) 8.0 Hz,
PhH), 7.37 (d, 2H, J ) 8.0 Hz, PhH), 5.88-5.64 (m, 15H),
4.92-4.53 (m, 15H), 3.69-3.12 (m, 42 H) 1.27 (s, 9H, t-Bu);
3
-(4-ter t-bu tylp h en yl)isoxa zole (13a ). The title compound
was prepared as a 1.5:1 mixture with the regioisomer 12a , in
6% yield, as described above from reaction of the CD 6 with
the nitrile oxide 11a in DMF. It was isolated by recrystalli-
1
3
8
C NMR δ 170.9 and 168.2 (CdO), 155.1 and 153.1 (quater-
nary), 126.8 and 125.4 (methine, Ph), 125.1 (quaternary, Ph),
102.5-101.6 (CD C-1), 83.1 and 81.8-81.3 (CD C-4), 82.7
(isoxazole C-5), 73.3-71.9 and 70.2 (CD C-2, C-3, and C-5),
60.4-59.7 (CD C-6), 58.3 (isoxazole C-4), 34.7 (quaternary,
1
zation and had the following: HPLC t
(
R
) 1.1; H NMR δ 8.76
m, 1H, NH), 7.82 (d, 2H, J ) 8.5 Hz, PhH), 7.58 [s, 1H,
isoxazole C(4)-H], 7.54 (d, 2H, J ) 8.5 Hz, PhH), 5.88-5.70
+
(
(
m, 14H), 4.95-4.77 (m, 7H), 4.53-4.35 (m, 6H), 3.84-3.26
t-Bu), 31.2 (methyl, t-Bu); ESI-MS (90 eV) m/z 1406 (M ). Anal.
1
3
m, 42H), 1.31 (s, 9H, t-Bu); C NMR δ 164.0, 162.2, 155.9
Calcd for C57
H
86
N
2
O
2
38‚8H O: C, 44.13; H, 6.63; N, 1.81.
and 153.3 (quaternary), 126.5 and 126.0 (methine, Ph), 125.1
quaternary, Ph), 104.4 (isoxazole C-4), 102.4-101.6 (CD C-1),
4.3 and 81.5-81.3 (CD C-4), 73.1-72.0 and 69.7 (CD C-2, C-3,
and C-5), 60.0-59.3 (CD C-6), 34.7 (quaternary, t-Bu), 31.1
Found: C, 44.14; H, 6.77; N, 1.75.
A
A
(
8
N-(6 -Deoxy-â-cyclod extr in -6 -yl)-5-(a m in oca r bon yl)-
3-(4-ter t-bu tylp h en yl)-4,5-d ih yd r oisoxa zole (15a ). The
title compound was prepared as a 4:1 mixture with the
regioisomer 14a , in 87% yield, as described above from reaction
of the CD 8a with the nitrile oxide 11a in DMF. It was
+
(
methyl, t-Bu); ESI-MS (50 eV) m/z 1383 (M + Na ). Anal.
Calcd for C56 O: C, 44.15; H, 6.74; N, 1.83.
Found: C, 44.00; H, 6.63; N, 1.59.
H
84
N
2
O
36‚9H
2
isolated by recrystallization and had the following: HPLC t
R
A
A
1
N-(6 -Deoxy-â-cyclod extr in -6 -yl)-5-(a m in oca r bon yl)-
-(4-bip h en yl)isoxa zole (13b). The title compound was
) 1.3; H NMR δ 7.93 (m, 1H, NH), 7.61 (d, 2H, J ) 8.5 Hz,
PhH), 7.47 (d, 2H, J ) 8.5 Hz, PhH), 5.84-5.68 (m, 14H), 5.09
[m, 1H, isoxazole C(5)-H], 4.89-4.81 (m, 7H), 4.74-4.34 (m,
6H), 3.86-3.14 (m, 44 H) 1.29 (s, 9H, t-Bu); 13C NMR δ 169.7,
156.4 and 153.2 (quaternary), 126.7 and 125.7 (methine, Ph),
125.9 (quaternary, Ph), 102.3-101.8 (CD C-1), 83.8 and 81.6-
81.4 (CD C-4), 78.9 (isoxazole C-5), 73.0-72.0 and 69.8 (CD
C-2, C-3, and C-5), 59.8-60.3 (CD C-6), 34.7 (quaternary, t-Bu),
3
prepared as a 5:1 mixture with the regioisomer 12b, in 93%
yield, as described above from reaction of the CD 6 with the
nitrile oxide 11b in DMF. It was isolated by recrystallization
1
and had the following: HPLC t
1
2
R
) 1.3; H NMR δ 8.81 (br s,
H, NH), 8.00 (d, J ) 4.2 Hz, 2H, PhH), 7.85 (d, J ) 7.5 Hz,
H, PhH), 7.75 (d, J ) 7.5 Hz, 2H, PhH), 7.66 [s, 1H, isoxazole
+
C(4)-H], 7.50 (m, 2H, PhH), 7.41 (m, 1H, PhH), 5.86-5.64
31.0 (methyl t-Bu); ESI-MS m/z 1385 (M + Na ). Anal. Calcd
(
(
(
m, 14H), 4.96-4.77 (m, 7H), 4.54-4.36 (m, 6H), 3.90-3.28
for C56
H
86
N
2
O
2
36‚7H O: C, 45.16; H, 6.77; N, 1.88. Found: C,
1
3
m, 42H); C NMR δ 164.2, 162.1, 155.7, 142.1 and 139.2
44.93; H, 6.47; N, 1.68.
A
A
quaternary), 129.1, 127.5, 127.4 and 126.8 (methine, Ph),
N-(6 -Deoxy-â-cyclod extr in -6 -yl)-5-(a m in oca r bon yl)-
3-p h en yl-4,5-d ih yd r oisoxa zole (15b). Reaction of the CD
8a with the nitrile oxide 11c in either aqueous solution or
DMF, as described above, gave the title compound 15b as the
only detectable cycloadduct. It was isolated by recrystalliza-
tion and had the following: 1H NMR δ 7.95 (m, 1H, NH), 7.68
(m, 2H, PhH), 7.44 (m, 3H, PhH), 5.84-5.67 (m, 14H), 5.10
[m, 1H, isoxazole C(5)-H], 4.89-4.80 (m, 7H), 4.52-4.36 (m,
1
28.1 (quaternary, Ph), 104.4 (isoxazole C-4), 102.4-101.4 (CD
C-1), 84.3 and 81.7-81.1 (CD C-4), 73.3-71.9 and 69.5 (CD
C-2, C-3, and C-5), 60.1-59.7 (CD C-6); ESI-MS (50 eV) m/z
+
1
403 (M + Na ). Anal. Calcd for C58
H
80
N
2
O
2
36‚3H O: C, 48.54;
H, 6.04; N, 1.95. Found: C, 48.60; H, 5.82; N, 2.03.
A
A
N-(6 -Deoxy-â-cyclod extr in -6 -yl)-5-(a m in oca r bon yl)-
3
-p h en ylisoxa zole (13c). The title compound was prepared
1
3
as a 10:1 mixture with the regioisomer 12c, in 87% yield, as
described above from reaction of the CD 6 with the nitrile oxide
6H), 3.82-3.10 (m, 44 H); C NMR δ 169.6 and 156.6
(quaternary), 130.4, 128.9 and 126.8 (methine, Ph), 128.7
(quaternary, Ph), 102.3-101.7 (CD C-1), 83.9 and 81.6-81.4
(CD C-4), 79.0 (isoxazole C-5), 73.0-72.0 and 69.7 (CD C-2,
1
1c in DMF. It was isolated by recrystallization and had the
1
following: HPLC t
m, 2H, PhH), 7.61 [s, 1H, isoxazole C(4)-H], 7.53 (m, 3H,
PhH), 5.87-5.67 (m, 14H), 4.95-4.77 (m, 7H), 4.53-4.35 (m,
R
) 3.1; H NMR δ 8.78 (m, 1H, NH), 7.91
+
(
C-3, and C-5), 60.2-59.6 (CD C-6); ESI-MS m/z 1306 (M ).
Anal. Calcd for C52
H
78
N
2
O
2
36‚7H O: C, 43.57; H, 6.47; N, 1.95.
6
H), 3.90-3.19 (m, 42H); 13C NMR δ 164.3, 162.5 and 155.9
Found: C, 43.84; H, 6.55; N, 2.02.
A
A
(quaternary), 130.8, 129.5 and 126.9 (methine, Ph), 128.0
N-(6 -Deoxy-â-cyclod extr in -6 -yl)-5-(a m in oca r bon yl)-
3-(4-ter t-bu tylph en yl)-4-(eth oxycar bon yl)-4,5-dih ydr oisox-
a zole (15c). The title compound was prepared as a 15:1
mixture with the regioisomer 14c, in 64% yield, as described
above from reaction of the CD 8b with the nitrile oxide 11a in
(
8
quaternary, Ph), 104.5 (isoxazole C-4), 102.4-101.5 (CD C-1),
4.3 and 81.7-81.2 (CD C-4), 73.3-72.0 and 69.6 (CD C-2, C-3,
+
and C-5), 60.1-59.4 (CD C-6); ESI-MS m/z 1328 (M + Na ).
Anal. Calcd for C52 O: C, 44.19; H, 6.28; N, 1.98.
Found: C, 44.09; H, 6.05; N, 1.91.
H
76
N
2
O
36‚6H
2
DMF. It was isolated by HPLC (acetonitrile/water, 10% v/v)
A
A
1
N-(6 -Deoxy-â-cyclod extr in -6 -yl)-4-(a m in oca r bon yl)-
and had the following: HPLC t
R
) 5.7; H NMR δ 8.25 (br s,
3
-(4-ter t-bu tylp h en yl)-4,5-d ih yd r oisoxa zole (14a ). The
1H, NH), 7.49 (d, 2H, J ) 8.5 Hz, PhH), 7.40 (d, 2H, J ) 8.5
Hz, PhH), 5.92-5.64 (m, 14H), 5.14 [d, 1H, J ) 6.5 Hz,
isoxazole C(5)-H], 4.92-4.77 (m, 8H), 4.55-4.48 (m, 3H),
title compound was prepared as a 2.3:1 mixture with the
regioisomer 15a , in 100% yield, as described above from
reaction of the CD 8a with the nitrile oxide 11a in aqueous
4.41-4.36 (m, 3H), 4.19 (m, 2H, OCH
2 3
CH ), 3.70-3.12 (m, 42
13
solution. It was isolated by HPLC (acetonitrile/water, 10% v/v)
H) 1.29 (s, 9H, t-Bu), 1.25 (t, 3H, J ) 7.5 Hz, OCH
2
CH
3
);
C
1
and had the following: HPLC t
1
R
) 1.6; H NMR δ 7.96 (br s,
NMR δ 169.2 and 168.0 (CdO), 155.1 and 153.4 (quaternary),
126.8 and 125.6 (methine, Ph), 124.8 (quaternary, Ph), 102.4-
101.7 (CD C-1), 82.9 and 81.4-81.2 (CD C-4), 82.1 (isoxazole
H, NH), 7.46 (d, 2H, J ) 8.0 Hz, PhH), 7.37 (d, 2H, J ) 8.0
Hz, PhH), 5.86-5.63 (m, 14H), 4.84-4.75 (m, 7H), 4.66 [m,
1
4
9
1
1
H, isoxazole C(5)-H], 4.60 [m, 1H, isoxazole C(5)-H′], 4.53-
.47 (m, 2H), 4.43-4.35 (m, 5H), 3.72-3.20 (m, 42H), 1.29 (s,
C-5), 73.0-71.9 and 69.8 (CD C-2, C-3, and C-5), 61.7 (OCH
CH ), 60.4-59.7 (CD C-6), 58.2 (isoxazole C-4), 34.7 (quater-
nary, t-Bu), 31.1 (methyl, t-Bu), 14.1 (OCH CH ); ESI-MS m/z
O: C, 45.91; H,
2
-
3
1
3
H, t-Bu); C NMR δ 169.1, 155.6 and 152.6 (quaternary),
26.6 and 125.2 (methine, Ph), 125.7 (quaternary, Ph), 102.2-
01.6 (CD C-1), 83.4 and 81.6 (CD C-4), 73.1-71.8 and 70.3
2
3
+
1435 (M ). Anal. Calcd for C59
H
90
N
2
O
38‚6H
2
6.66; N, 1.82. Found: C, 45.81; H, 6.28; N, 2.11.
(
CD C-2, C-3, and C-5), 60.4 (isoxazole C-5), 59.9-59.5 (CD
C-6), 54.8 (isoxazole C-4), 34.6 (quaternary, t-Bu), 31.2 (methyl,
3-(4-ter t-Bu tylp h en yl)-5-(m eth oxyca r bon yl)isoxa zole
(17). To a stirred solution of methyl propynoate (16) (25 mg,